Private Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.1M | Sell |
63,285
-29
| -0% | -$15.7K | 2.4% | 13 |
|
|
2025
Q4 | $36.7M | Sell |
63,314
-3,844
| -6% | -$2.17M | 2.6% | 10 |
|
|
2025
Q3 | $32.6M | Buy |
67,158
+2,458
| +4% | +$1.14M | 2.32% | 11 |
|
|
2025
Q2 | $26.2M | Buy |
64,700
+4,342
| +7% | +$1.82M | 2.05% | 12 |
|
|
2025
Q1 | $30M | Sell |
60,358
-2,845
| -5% | -$1.54M | 2.49% | 12 |
|
|
2024
Q4 | $32.9M | Buy |
63,203
+3,197
| +5% | +$1.76M | 2.52% | 9 |
|
|
2024
Q3 | $37.1M | Sell |
60,006
-16,004
| -21% | -$9.47M | 2.96% | 8 |
|
|
2024
Q2 | $42M | Sell |
76,010
-7,883
| -9% | -$4.52M | 3.12% | 9 |
|
|
2024
Q1 | $48.8M | Sell |
83,893
-1,238
| -1% | -$695K | 3.9% | 7 |
|
|
2023
Q4 | $45.2M | Buy |
85,131
+815
| +1% | +$394K | 3.82% | 6 |
|
|
2023
Q3 | $42.7M | Buy |
84,316
+776
| +0.9% | +$414K | 4.08% | 6 |
|
|
2023
Q2 | $43.6M | Sell |
83,540
-674
| -0.8% | -$364K | 4.01% | 6 |
|
|
2023
Q1 | $48.5M | Sell |
84,214
-8,592
| -9% | -$4.84M | 4.85% | 4 |
|
|
2022
Q4 | $51.1M | Buy |
92,806
+1,968
| +2% | +$1.04M | 5.85% | 3 |
|
|
2022
Q3 | $46.1M | Buy |
90,838
+1,240
| +1% | +$694K | 5.89% | 3 |
|
|
2022
Q2 | $48.7M | Sell |
89,598
-1,879
| -2% | -$1.03M | 5.66% | 3 |
|
|
2022
Q1 | $54M | Buy |
91,477
+394
| +0.4% | +$226K | 4.84% | 5 |
|
|
2021
Q4 | $60.8M | Sell |
91,083
-3,403
| -4% | -$2.12M | 5.14% | 5 |
|
|
2021
Q3 | $54M | Sell |
94,486
-302
| -0.3% | -$166K | 5.01% | 5 |
|
|
2021
Q2 | $47.8M | Sell |
94,788
-232
| -0.2% | -$109K | 4.42% | 6 |
|
|
2021
Q1 | $43.4M | Sell |
95,020
-1,094
| -1% | -$522K | 4.59% | 6 |
|
|
2020
Q4 | $44.8M | Buy |
96,114
+198
| +0.2% | +$92.8K | 4.86% | 5 |
|
|
2020
Q3 | $42.3M | Buy |
95,916
+353
| +0.4% | +$146K | 4.95% | 5 |
|
|
2020
Q2 | $34.6M | Sell |
95,563
-2,343
| -2% | -$785K | 4.74% | 5 |
|
|
2020
Q1 | $27.8M | Sell |
97,906
-2,020
| -2% | -$637K | 4.68% | 6 |
|
|
2019
Q4 | $32.5M | Sell |
99,926
-275
| -0.3% | -$83.4K | 4.42% | 7 |
|
|
2019
Q3 | $29.2M | Sell |
100,201
-665
| -0.7% | -$190K | 4.54% | 6 |
|
|
2019
Q2 | $29.6M | Buy |
100,866
+345
| +0.3% | +$95K | 4.56% | 5 |
|
|
2019
Q1 | $27.5M | Sell |
100,521
-1,047
| -1% | -$261K | 4.53% | 6 |
|
|
2018
Q4 | $22.7M | Buy |
101,568
+12,759
| +14% | +$2.99M | 4.4% | 6 |
|
|
2018
Q3 | $21.7M | Buy |
88,809
+125
| +0.1% | +$28.8K | 3.31% | 7 |
|
|
2018
Q2 | $18.4M | Sell |
88,684
-4,472
| -5% | -$949K | 3.09% | 7 |
|
|
2018
Q1 | $19.2M | Buy |
93,156
+1,002
| +1% | +$210K | 3.35% | 7 |
|
|
2017
Q4 | $17.5M | Buy |
92,154
+1,771
| +2% | +$339K | 3.24% | 7 |
|
|
2017
Q3 | $17.1M | Buy |
90,383
+4,824
| +6% | +$874K | 3.44% | 7 |
|
|
2017
Q2 | $14.9M | Sell |
85,559
-427
| -0.5% | -$71.7K | 3.24% | 9 |
|
|
2017
Q1 | $13.2M | Buy |
85,986
+7,746
| +10% | +$1.18M | 2.93% | 13 |
|
|
2016
Q4 | $11M | Buy |
78,240
+25,705
| +49% | +$3.79M | 2.62% | 15 |
|
|
2016
Q3 | $8.36M | Sell |
52,535
-200
| -0.4% | -$30.8K | 2.01% | 17 |
|
|
2016
Q2 | $7.79M | Hold |
52,735
| – | – | 1.87% | 16 |
|
|
2016
Q1 | $7.47M | Buy |
52,735
+760
| +1% | +$102K | 1.79% | 18 |
|
|
2015
Q4 | $7.37M | Sell |
51,975
-950
| -2% | -$127K | 1.72% | 17 |
|
|
2015
Q3 | $6.47M | Sell |
52,925
-7,225
| -12% | -$941K | 1.63% | 18 |
|
|
2015
Q2 | $7.8M | Buy |
60,150
+200
| +0.3% | +$26.1K | 1.76% | 18 |
|
|
2015
Q1 | $8.05M | Sell |
59,950
-5,000
| -8% | -$645K | 1.85% | 16 |
|
|
2014
Q4 | $8.14M | Sell |
64,950
-900
| -1% | -$109K | 1.91% | 17 |
|
|
2014
Q3 | $8.01M | Sell |
65,850
-1,425
| -2% | -$173K | 1.76% | 18 |
|
|
2014
Q2 | $7.94M | Sell |
67,275
-6,025
| -8% | -$709K | 1.74% | 19 |
|
|
2014
Q1 | $8.81M | Sell |
73,300
-22,175
| -23% | -$2.64M | 2.08% | 17 |
|
|
2013
Q4 | $10.6M | Sell |
95,475
-3,450
| -3% | -$343K | 2.37% | 12 |
|
|
2013
Q3 | $9.12M | Sell |
98,925
-650
| -0.7% | -$58.8K | 2.16% | 12 |
|
|
2013
Q2 | $8.43M | Buy |
+99,575
| New | +$8.29M | 2.1% | 16 |
|
Other funds holding TMO
VCM
Private Wealth Partners's TMO Position: Q1 2026 in Review
Private Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.05% in Q1 2026, selling an estimated $15.7K and leaving 63,285 shares worth $31.1M. The position accounts for 2.4% of the portfolio, ranked #13.
Private Wealth Partners first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $60.8M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Private Wealth Partners held 63,285 shares of Thermo Fisher Scientific worth $31.1M as of Q1 2026.
- Private Wealth Partners sold 29 Thermo Fisher Scientific shares in Q1 2026, an estimated $15.7K.
- Thermo Fisher Scientific made up 2.4% of Private Wealth Partners's portfolio in Q1 2026, its #13 holding.
- Private Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Private Wealth Partners's Thermo Fisher Scientific position peaked at $60.8M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.